Clarivate Plc

Clarivate Plc engages in the provision of global information, analytics and workflow solutions. It operates through the Science and Intellectual Property segments. The Science segment is composed of the academia and government, and life science and healthcare product lines. The Intellectual Property segment includes the patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clarivate Plc reports strong Q4 earnings, eyes growth opportunities

Clarivate Plc delivered strong financial results in Q4 2022, driven by the successful ProQuest acquisition and solid organic growth across segments. The company is focused on achieving higher organic growth, reducing leverage, and leveraging culture for success.
While facing macroeconomic challenges and pricing pressures, Clarivate Plc is confident in its strategic plans and capital structure initiatives. Opportunities lie in leveraging AI, enhancing product offerings, and capitalizing on the positive pricing environment.
Navigating challenges such as tough comps, managing inflation impact, and balancing quarterly patterns will be crucial. The company's proactive approach to growth, focus on customer value, and upcoming Investor Day position it well for future success.

Clarivate Plc reports stable Q1 performance amidst growth challenges

Clarivate Plc's Q1 2023 performance showcased stable revenue, strong margins, and strategic financial initiatives despite challenges in net income and organic growth cadence.
The company's strengths lie in market engagement, AI innovation, maintained outlook, and effective pricing strategies, positioning it for continued growth.
Challenges include earnings volatility, execution hurdles in growth projections, and longer-term segment revenue impacts, necessitating strategic planning and operational focus.
Opportunities in AI applications, cash flow utilization, revenue drivers, and segment progress offer avenues for revenue diversification, growth investments, and market expansion.

Clarivate Plc faces revenue challenges but drives growth through innovation

Clarivate Plc's Q2 performance saw challenges in key segments impacting revenue and outlook, despite operational improvements and strategic initiatives.
While facing hurdles in patent annuities and commercialization subsegment growth, the company focuses on sustainability, product innovations, and customer-centric strategies for future growth.
Detailed financial results and revised guidance reflect the company's proactive approach to address challenges and capitalize on opportunities for sustainable growth.
With a pivot around three segments and emphasis on higher-touch sales, Clarivate aims to navigate challenges, leverage opportunities, and drive revenue growth in the evolving market landscape.

Clarivate Plc reports Q3 growth, tackles challenges, eyes tech acquisitions

Clarivate Plc's Q3 performance showed growth in key segments despite challenges in IP and LS&H businesses.
Opportunities lie in technology acquisitions, analytic platforms, and direct sales to pharma companies.
Management remains optimistic about quarterly results and progress, focusing on enhancing growth strategies.

Clarivate Plc reports solid Q4 performance amidst sector challenges

Clarivate Plc's Q4 2023 performance reflects progress in key segments and a strategic focus on organic growth and operational efficiencies.
While facing challenges in the A&G segment and market conservatism, the company is leveraging strengths in Life Sciences investments and pricing strategies.
Opportunities lie in growth acceleration through new offerings, improved organic growth, and renewed optimism in the life sciences sector.

Clarivate Plc reports Q1 revenue growth, eyes segment expansion

Clarivate Plc's Q1 performance showed promising organic revenue growth and steady renewal rates, with a focus on future investments for growth.
While facing financial challenges and neutral market conditions, the company sees opportunities in segment growth and real-world data solutions.
Overall, Clarivate remains on track with full-year guidance, aiming for 1% organic growth and focusing on driving subscription business growth.

Clarivate Plc reports mixed Q2 results, focuses on growth strategies

Clarivate Plc reported mixed financial results in Q2 2024, with slight revenue growth but challenges in certain segments.
Management emphasized resilience in adjusted EPS and operating cash flow, focusing on growth plans and operational improvements.
Analysts raised concerns about project delays and segment performance, but opportunities in product innovation and revenue growth were highlighted.
The company aims to drive subscription revenue growth through upcoming product releases and investment in business.

Clarivate Plc faces revenue decline in Q3 but focuses on growth strategies

Clarivate Plc's Q3 2024 earnings call highlighted challenges in revenue decline and net loss, with a focus on repositioning and value creation. The company is implementing a Value Creation Plan to optimize its business model and drive sustainable growth. Opportunities exist in improving sales execution, product innovation, and aligning the portfolio for enhanced profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). The A&G segment involves the provision of research and analytics, content aggregation, and workflow software solutions using artificial intelligence. The IP segment includes the maintenance, intelligence, and management solutions. The LS&H focuses on solutions for research and development, regulatory and safety, and commercialization. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Cortellis Deals Intelligence features new trends visualizations and predictive analytics supported by artificial intelligence  LONDON, April 22, 2021 /PRNewswire/ --  Clarivate Plc  (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the enhancement of Cortellis Deals Intelligence, a leading industry source of life science deals information. The new features include deal trend visualizations and predictive analytics, allowing users to confidently track the deal-making landscape and quickly understand the potential value of an asset.

Clarivate Releases Predictive Analytics to Help Fuel Life Sciences Deal Making Landscape

LONDON, April 14, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today published its first ever Annual Sustainability Report. The interactive report outlines the progress Clarivate made in 2020 in the areas of Governance, Environment, Colleagues and Community, and presents plans for 2021 as well as long term goals for the business.

Clarivate Releases Annual Sustainability Report Outlining 2020 Progress and Plans for the Future

LONDON, April 12, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the appointment of Julie Wilson as Chief People Officer (CPO). She replaces Andrea Degutis who retires after four years at the helm of Clarivate Human Resources.

Clarivate Appoints Julie Wilson as Chief People Officer and Announces Retirement of Andrea Degutis

LONDON, April 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a report which explores the seismic shift of the research landscape in 19 countries across the Middle East, North Africa and Turkey (MENAT) region over recent decades. It presents an international success story, with the region's global share of research output quadrupling from 2% to 8% over the last 40 years, and papers from 22 million individual researchers identified within the region between 2008 and 2017.

Clarivate Global Research Report Outlines Rising Impact in MENAT Research Due to Strong International Collaboration

LONDON, March 12, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the BofA Securities 2021 Information Services Conference on Thursday, March 18, 2021 at 3:35 PM Eastern Time. A live webcast of the event will be available on the Investor Relations section of the Clarivate website at http://ir.clarivate.com/Event-Calendar.

Clarivate to Present at the BofA Securities 2021 Information Services Conference on March 18, 2021

Drug developers advance milestone treatments for chronic and progressive conditions affecting millions of patients worldwide, including Alzheimer's, psoriasis, prostate cancer and congestive heart failure Report also features snapshot of the fast-emerging field of COVID-19 vaccines...

Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021

LONDON, March 1, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new interactive tool that showcases the range of a researcher's publication and citation impact in a...

Clarivate Releases New Visualization Tool for Multi-Dimensional Individual Researcher Performance

Clarivate Plc (CLVT) CEO Jerre Stead on Q4 2020 Results - Earnings Call Transcript

Clarivate PLC (CLVT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Clarivate PLC (CLVT) Upgraded to Buy: Here's What You Should Know

LONDON, Feb. 26, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial...

Clarivate to Present at the Morgan Stanley Technology, Media and Telecom Conference on March 4, 2021

The analytics specialist reports fourth-quarter results as the broader market sells off.

Why Clarivate Stock Cratered Today

Clarivate PLC (CLVT) delivered earnings and revenue surprises of 29.41% and -3.45%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Clarivate PLC (CLVT) Tops Q4 Earnings Estimates

LONDON, Feb. 25, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, today reported results for the fourth quarter and year ended December 31, 2020. Fourth...

Clarivate Reports Fourth Quarter and Full Year 2020 Results

10-time recipients demonstrated greater market capitalization growth than Dow Jones Industrial Average or S&P 500, according to latest Clarivate Top 100 Global Innovators report LONDON, Feb. 23, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted...

10th Edition of Clarivate Top 100 Global Innovators Report Celebrates Innovation Excellence and Quantifies Economic Value of Ideation

The proliferation of trademarks and the corresponding increase in infringements present significant challenges and consequences for businesses LONDON, Feb. 18, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the...

Revenue Opportunities Are Missed When The C-suite Doesn't Pay Attention, Says New Clarivate Report

LONDON, Feb. 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a report that examines the organization of information in the global scientific community and introduces a...

News for Clarivate Plc Stock (CLVT)